|
|
Article: Cardiac Dimensions(R) Inc. Announces Completion of Enrollment in AMADEUS(TM) Trial with the CARILLON(TM) Mitral Contour System(TM).
- Article from:
- Business Wire
- Article date:
- October 2, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
30 Patient Safety & Efficacy Study in Europe is First with CARILLON[TM] Device
KIRKLAND, Wash. -- Cardiac Dimensions[R] Inc., a developer of devices to treat heart failure and related conditions, today announced that it has completed enrollment in the AMADEUS[TM] trial. AMADEUS[TM] (CArillon Mitral Annuloplasty Device European Union Study), a safety and efficacy study, is evaluating the CARILLON[TM] system at six centers across Europe. In June, Professor Tomasz Siminiak of the Poznan University of Medical Sciences Cardiac & Rehabilitation Hospital, implanted the final CARILLON[TM] devices while in Poznan, Poland. The study enrolled 30 patients and is designed to ...